ArticlePharmaceutics2020

Conjugation of Therapeutic PSD-95 Inhibitors to the Cell-Penetrating Peptide Tat Affects Blood-Brain Barrier Adherence, Uptake, and Permeation.

Mie Kristensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.